Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 7/20 | 0.58 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.38 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.37 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3792049 | 0.91 | PTGDR2 (0.47) | PTGDR2BACE1SLC6A9BRD4KDM4C | |
| SCHEMBL3792023 | 0.90 | PTGDR2 (0.47) | PTGDR2BRD4ALDH1A1TUBB4ATUBB | |
| SCHEMBL3786324 | 0.88 | PTGDR2 (0.48) | PTGDR2BACE1NCOA1NCOA3ALDH1A1 | |
| SCHEMBL3780727 | 0.84 | PTGDR2 (0.40) | PTGDR2BRD4KDM4CNCOA1ALDH1A1 | |
| SCHEMBL3785148 | 0.81 | NCOA1 (0.46) | PTGDR2BACE1NCOA1NCOA3ALDH1A1 | |
| SCHEMBL3785067 | 0.81 | PTGDR2 (0.61) | PTGDR2BACE1ALDH1A1NPC1ADORA3 | |
| SCHEMBL3789776 | 0.81 | ADRA2A (0.43) | BRD4ALDH1A1TUBB4ATUBBTUBA3C | |
| SCHEMBL3790313 | 0.80 | NCOA1 (0.41) | PTGDR2BACE1NCOA1NCOA3ALDH1A1 | |
| SCHEMBL3791104 | 0.78 | ALDH1A1 (0.39) | PTGDR2BACE1ALDH1A1TUBB4ATUBB | |
| SCHEMBL3781473 | 0.78 | TUBB4A (0.40) | PTGDR2BRD4ALDH1A1TUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | PTGDR2 3672/4885BACE1 925/4885SLC6A9 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.